Zinc Oxide Nanoparticles Induce Mitochondrial Biogenesis Impairment and Cardiac Dysfunction in Human iPSC-Derived Cardiomyocytes

References

• Liu J, Feng X, Wei L, Chen L, Song B, Shao L. The toxicology of ion-shedding zinc oxide nanoparticles. Crit Rev Toxicol. 2016;46(4):348–384. doi:10.3109/10408444.2015.113786426963861
   PubMed Web of Science ®Google Scholar
• Jacobsen NR, Stoeger T, van den Brule S, et al. Acute and subacute pulmonary toxicity and mortality in mice after intratracheal instillation of ZnO nanoparticles in three laboratories. Food Chem Toxicol. 2015;85:84–95. doi:10.1016/j.fct.2015.08.00826260750
   PubMed Web of Science ®Google Scholar
• Danielsen PH, Cao Y, Roursgaard M, Moller P, Loft S. Endothelial cell activation, oxidative stress and inflammation induced by a panel of metal-based nanomaterials. Nanotoxicology. 2015;9(7):813–824. doi:10.3109/17435390.2014.98044925405261
   PubMed Web of Science ®Google Scholar
• Konduru NV, Murdaugh KM, Sotiriou GA, et al. Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles. Part Fibre Toxicol. 2014;11:44. doi:10.1186/s12989-014-0044-625183210
   PubMed Web of Science ®Google Scholar
• Esmaeillou M, Moharamnejad M, Hsankhani R, Tehrani AA, Maadi H. Toxicity of ZnO nanoparticles in healthy adult mice. Environ Toxicol Pharmacol. 2013;35(1):67–71. doi:10.1016/j.etap.2012.11.00323262039
   PubMed Web of Science ®Google Scholar
• Li CH, Shen CC, Cheng YW, et al. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology. 2012;6(7):746–756. doi:10.3109/17435390.2011.62071721950449
   PubMed Web of Science ®Google Scholar
• Xiaoli F, Junrong W, Xuan L, et al. Prenatal exposure to nanosized zinc oxide in rats: neurotoxicity and postnatal impaired learning and memory ability. Nanomedicine (Lond). 2017;12(7):777–795. doi:10.2217/nnm-2016-039728322126
   PubMed Web of Science ®Google Scholar
• Kielbik P, Kaszewski J, Rosowska J, et al. Biodegradation of the ZnO:Eu nanoparticles in the tissues of adult mouse after alimentary application. Nanomedicine. 2017;13(3):843–852. doi:10.1016/j.nano.2016.11.00227884640
   PubMed Web of Science ®Google Scholar
• Cao Y, Gong Y, Liao W, et al. A review of cardiovascular toxicity of TiO2, ZnO and Ag nanoparticles (NPs). Biometals. 2018;31(4):457–476. doi:10.1007/s10534-018-0113-729748744
   PubMed Web of Science ®Google Scholar
• Monse C, Hagemeyer O, Raulf M, et al. Concentration-dependent systemic response after inhalation of nano-sized zinc oxide particles in human volunteers. Part Fibre Toxicol. 2018;15(1):8. doi:10.1186/s12989-018-0246-429429408
   PubMedGoogle Scholar
• Baky NA, Faddah LM, Al-Rasheed NM, Al-Rasheed NM, Fatani AJ. Induction of inflammation, DNA damage and apoptosis in rat heart after oral exposure to zinc oxide nanoparticles and the cardioprotective role of alpha-lipoic acid and vitamin E. Drug Res. 2013;63(5):228–236. doi:10.1055/s-0033-1334923
   Google Scholar
• Chuang HC, Juan HT, Chang CN, et al. Cardiopulmonary toxicity of pulmonary exposure to occupationally relevant zinc oxide nanoparticles. Nanotoxicology. 2014;8(6):593–604. doi:10.3109/17435390.2013.80980923738974
   PubMed Web of Science ®Google Scholar
• Bengalli R, Gualtieri M, Capasso L, Urani C, Camatini M. Impact of zinc oxide nanoparticles on an in vitro model of the human air-blood barrier. Toxicol Lett. 2017;279:22–32. doi:10.1016/j.toxlet.2017.07.87728709982
   PubMed Web of Science ®Google Scholar
• Yan Z, Wang W, Wu Y, et al. Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo. Int J Nanomedicine. 2017;12:4433–4442. doi:10.2147/IJN.S13489728652743
   PubMed Web of Science ®Google Scholar
• Bessemer RA, Butler KM, Tunnah L, et al. Cardiorespiratory toxicity of environmentally relevant zinc oxide nanoparticles in the freshwater fish Catostomus commersonii. Nanotoxicology. 2015;9(7):861–870. doi:10.3109/17435390.2014.98273725427894
   PubMed Web of Science ®Google Scholar
• Chuang KJ, Lee KY, Pan CH, et al. Effects of zinc oxide nanoparticles on human coronary artery endothelial cells. Food Chem Toxicol. 2016;93:138–144. doi:10.1016/j.fct.2016.05.00827185063
   PubMed Web of Science ®Google Scholar
• Liang S, Sun K, Wang Y, et al. Role of Cyt-C/caspases-9,3, Bax/Bcl-2 and the FAS death receptor pathway in apoptosis induced by zinc oxide nanoparticles in human aortic endothelial cells and the protective effect by alpha-lipoic acid. Chem Biol Interact. 2016;258:40–51. doi:10.1016/j.cbi.2016.08.01327544635
   PubMed Web of Science ®Google Scholar
• Handral HK, Tong HJ, Islam I, Sriram G, Rosa V, Cao T. Pluripotent stem cells: an in vitro model for nanotoxicity assessments. J Appl Toxicol. 2016;36(10):1250–1258. doi:10.1002/jat.334727241574
   PubMed Web of Science ®Google Scholar
• Magdy T, Schuldt AJT, Wu JC, Bernstein D, Burridge PW. Human induced pluripotent stem cell (hiPSC)-derived cells to assess drug cardiotoxicity: opportunities and problems. Annu Rev Pharmacol Toxicol. 2018;58:83–103. doi:10.1146/annurev-pharmtox-010617-05311028992430
   PubMed Web of Science ®Google Scholar
• Karakikes I, Ameen M, Termglinchan V, Wu JC. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ Res. 2015;117(1):80–88. doi:10.1161/CIRCRESAHA.117.30536526089365
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Yamanaka S. Induced pluripotent stem cells 10 years later: for cardiac applications. Circ Res. 2017;120(12):1958–1968. doi:10.1161/CIRCRESAHA.117.31108028596174
   PubMed Web of Science ®Google Scholar
• Cui N, Wu F, Lu WJ, et al. Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIalpha to IIbeta in human stem cell derived cardiomyocytes. J Cell Mol Med. 2019;23(7):4627–4639. doi:10.1111/jcmm.1434631106979
   PubMed Web of Science ®Google Scholar
• Yin J, Guo J, Zhang Q, et al. Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway. Toxicol in Vitro. 2018;51:1–10. doi:10.1016/j.tiv.2018.05.00129729358
   PubMed Web of Science ®Google Scholar
• Bostan HB, Rezaee R, Valokala MG, et al. Cardiotoxicity of nano-particles. Life Sci. 2016;165:91–99. doi:10.1016/j.lfs.2016.09.01727686832
   PubMed Web of Science ®Google Scholar
• Guo C, Wang J, Jing L, et al. Mitochondrial dysfunction, perturbations of mitochondrial dynamics and biogenesis involved in endothelial injury induced by silica nanoparticles. Environ Pollut. 2018;236:926–936. doi:10.1016/j.envpol.2017.10.06029074197
   PubMed Web of Science ®Google Scholar
• Gustafsson CM, Falkenberg M, Larsson NG. Maintenance and expression of mammalian mitochondrial DNA. Annu Rev Biochem. 2016;85:133–160. doi:10.1146/annurev-biochem-060815-01440227023847
   PubMed Web of Science ®Google Scholar
• Wenz T. Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion. 2013;13(2):134–142. doi:10.1016/j.mito.2013.01.00623347985
   PubMed Web of Science ®Google Scholar
• Birket MJ, Casini S, Kosmidis G, et al. PGC-1alpha and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Rep. 2013;1(6):560–574. doi:10.1016/j.stemcr.2013.11.008
   PubMed Web of Science ®Google Scholar
• Sun J, Wang S, Zhao D, Hun FH, Weng L, Liu H. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol Toxicol. 2011;27(5):333–342. doi:10.1007/s10565-011-9191-921681618
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu Y, Quadri F, Prox JD, Guo L. Cytotoxicity of ZnO nanowire arrays on excitable cells. Nanomaterials (Basel). 2017;7(4):80. doi:10.3390/nano7040080
   PubMedGoogle Scholar
• Blinova K, Dang Q, Millard D, et al. International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment. Cell Rep. 2018;24(13):3582–3592. doi:10.1016/j.celrep.2018.08.07930257217
   PubMed Web of Science ®Google Scholar
• Wang M, Wang J, Liu Y, et al. Subcellular targets of zinc oxide nanoparticles during the aging process: role of cross-talk between mitochondrial dysfunction and endoplasmic reticulum stress in the genotoxic response. Toxicol Sci. 2019;171(1):159–171. doi:10.1093/toxsci/kfz132
   PubMed Web of Science ®Google Scholar
• Wang MM, Wang YC, Wang XN, et al. Mutagenicity of ZnO nanoparticles in mammalian cells: role of physicochemical transformations under the aging process. Nanotoxicology. 2015;9(8):972–982. doi:10.3109/17435390.2014.99281625676621
   PubMed Web of Science ®Google Scholar
• Wang Y, Ding L, Yao C, et al. Toxic effects of metal oxide nanoparticles and their underlying mechanisms. Sci China Mater. 2017;60(2):93–108. doi:10.1007/s40843-016-5157-0
   Web of Science ®Google Scholar
• Pfanner N, Warscheid B, Wiedemann N. Mitochondrial proteins: from biogenesis to functional networks. Nat Rev Mol Cell Biol. 2019;20(5):267–284. doi:10.1038/s41580-018-0092-030626975
   PubMed Web of Science ®Google Scholar
• Park YH, Bae HC, Kim J, Jeong SH, Yang SI, Son SW. Zinc oxide nanoparticles induce HIF-1alpha protein stabilization through increased reactive oxygen species generation from electron transfer chain complex III of mitochondria. J Dermatol Sci. 2018;91(1):104–107. doi:10.1016/j.jdermsci.2018.03.01029622477
   PubMed Web of Science ®Google Scholar
• Babele PK, Thakre PK, Kumawat R, Tomar RS. Zinc oxide nanoparticles induce toxicity by affecting cell wall integrity pathway, mitochondrial function and lipid homeostasis in Saccharomyces cerevisiae. Chemosphere. 2018;213:65–75. doi:10.1016/j.chemosphere.2018.09.02830212720
   PubMed Web of Science ®Google Scholar
• Zhao X, Ren X, Zhu R, Luo Z, Ren B. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria-mediated apoptosis in zebrafish embryos. Aquat Toxicol. 2016;180:56–70. doi:10.1016/j.aquatox.2016.09.01327658222
   PubMed Web of Science ®Google Scholar
• Pohjoismaki JL, Goffart S. The role of mitochondria in cardiac development and protection. Free Radic Biol Med. 2017;106:345–354. doi:10.1016/j.freeradbiomed.2017.02.03228216385
   PubMed Web of Science ®Google Scholar
• Guo J, Guo Q, Fang H, et al. Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1alpha pathway. Eur J Pharmacol. 2014;737:117–124. doi:10.1016/j.ejphar.2014.05.01724858368
   PubMed Web of Science ®Google Scholar
• Yuan H, Zhang Q, Guo J, et al. A PGC-1alpha-mediated transcriptional network maintains mitochondrial redox and bioenergetic homeostasis against doxorubicin-induced toxicity in human cardiomyocytes: implementation of TT21C. Toxicol Sci. 2016;150(2):400–417. doi:10.1093/toxsci/kfw00626781513
   PubMed Web of Science ®Google Scholar
• Kussauer S, David R, Lemcke H. hiPSCs derived cardiac cells for drug and toxicity screening and disease modeling: what micro- electrode-array analyses can tell us. Cells. 2019;8(11):1331. doi:10.3390/cells8111331
   PubMed Web of Science ®Google Scholar
• Millard D, Dang Q, Shi H, et al. Cross-site reliability of human induced pluripotent stem cell-derived cardiomyocyte based safety assays using microelectrode arrays: results from a blinded CiPA pilot study. Toxicol Sci. 2018;164(2):550–562. doi:10.1093/toxsci/kfy11029718449
   PubMed Web of Science ®Google Scholar
• Du J, Wang S, You H, Jiang R, Zhuang C, Zhang X. Developmental toxicity and DNA damage to zebrafish induced by perfluorooctane sulfonate in the presence of ZnO nanoparticles. Environ Toxicol. 2016;31(3):360–371. doi:10.1002/tox.2205025258305
   PubMed Web of Science ®Google Scholar
• Haberl N, Hirn S, Holzer M, Zuchtriegel G, Rehberg M, Krombach F. Effects of acute systemic administration of TiO2, ZnO, SiO2, and Ag nanoparticles on hemodynamics, hemostasis and leukocyte recruitment. Nanotoxicology. 2015;9(8):963–971. doi:10.3109/17435390.2014.99281525670207
   PubMed Web of Science ®Google Scholar
• Li S, Pan H, Tan C, et al. Mitochondrial dysfunctions contribute to hypertrophic cardiomyopathy in patient iPSC-derived cardiomyocytes with MT-RNR2 mutation. Stem Cell Rep. 2018;10(3):808–821. doi:10.1016/j.stemcr.2018.01.013
   PubMed Web of Science ®Google Scholar